Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting

Affiliation auteurs!!!! Error affiliation !!!!
TitreEvaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting
Type de publicationJournal Article
Year of Publication2016
AuteursWardelmann E., Haas R.L, Bovee J.VMG, Terrier P, Lazar A., Messiou C., LePechoux C., Hartmann W., Collin F., Fisher C., Mechtersheimer G., DeiTos A.P, Stacchiotti S., Jones R.L, Gronchi A., Bonvalot S.
JournalEUROPEAN JOURNAL OF CANCER
Volume53
Pagination84-95
Date PublishedJAN
Type of ArticleArticle
ISSN0959-8049
Mots-clésChemotherapy, Guideline, Pathology, radiotherapy, response evaluation, soft tissue sarcoma
Résumé

At present, there is not a commonly used and generally accepted standardized approach for the pathologic evaluation of pretreated soft tissue sarcomas. Also, it is still unclear whether the cut-off for prognostic relevance is similar in the many different histological subtypes of STS. This manuscript, produced by a European Organization for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) endorsed task force, aims to propose standardization of the pathological examination process and the reporting of STS resection specimens after neoadjuvant radio-and/or chemotherapy. (C) 2015 Elsevier Ltd. All rights reserved.

DOI10.1016/j.ejca.2015.09.021